Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
about
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587.Waldenstrom's Macroglobulinemia: An Update.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Regulation of Malignant Hematopoiesis by Bone Marrow Microenvironment.Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma.A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics.CXCR4-directed theranostics in oncology and inflammationPotential use of compounds from sea cucumbers as MDM2 and CXCR4 inhibitors to control cancer cell growth
P2860
Q33708995-FDCB374F-3D07-4675-A615-933756113FB1Q37683451-38C86B2C-E8DE-4DF8-B3AC-485997E14D36Q37737798-A14834DF-019D-4BB9-9CD6-BD8646996B4DQ38947056-27928D87-0FFA-4814-AD3A-67B339BE44BBQ41695046-723E872D-2CCE-4F35-82AD-68A4CBA0DE1EQ45865484-244EEA79-9014-4D88-8883-DA937B90532DQ46246670-BADF584B-BCBC-4C8E-BAEB-FF6C615D882CQ47736653-DE5320D6-D4C6-4359-9E2F-89A68F092FDBQ49539698-8895844A-C950-4EE7-A6D7-4CD3AFDA9D5CQ54968394-1C8F8BC6-F060-44A7-A032-75B3E9EE54AFQ55059834-E3C0AFAA-6819-40FE-A8B3-89CDDF7D8CB8Q55262531-B6AC33F3-9F04-41E1-9B02-5E937EE3BBE0Q58783862-8C9F9FFA-2E91-4DF8-9B0D-3322B157319CQ58796650-80FE4751-2135-4A0D-B93E-6DD273781CD9
P2860
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@ast
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@en
type
label
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@ast
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@en
prefLabel
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@ast
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@en
P2093
P2860
P1433
P1476
Inhibition of CXCR4 by LY26245 ...... is of Hematologic Malignancies
@en
P2093
Donald Paul
Haiyan Long
Julie Stewart
Lisa M Kays
Louis F Stancato
Mark T Uhlik
Michele Dowless
Peter Vaillancourt
Shaoyou Chu
P2860
P304
P356
10.1371/JOURNAL.PONE.0150585
P407
P577
2016-03-08T00:00:00Z